Home › NDC Lookup › RxCUI directory › RxCUI 2611794

Methocarbamol 1000 MG Oral Tablet — RxCUI 2611794

Name: Methocarbamol 1000 MG Oral Tablet (RxCUI 2611794)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2611794 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2611794

Official nameMethocarbamol 1000 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped8

Package NDCs mapped11

Reported Medicaid activity (SDUD)5,533 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methocarbamol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Methocarbamol is a muscle relaxant that works through your central nervous system — your brain and spinal cord — rather than directly on the muscles themselves. It's thought to red...
What exactly does methocarbamol do? Will it make my muscles stop hurting?
You really should not. Methocarbamol already causes drowsiness and slows your central nervous system down. Adding alcohol on top of that significantly increases those effects — we'...
Be careful, especially when you first start taking it. Methocarbamol can impair your alertness, coordination, and reaction time. Don't drive or operate heavy machinery until you kn...

📖 Read our full Methocarbamol guide →

🕸️ Concept Web — How Methocarbamol 1000 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Methocarbamol 1000 MG Oral Tablet RxCUI 2611794 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Methocarbamol 6845 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tanlor 2690995 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Methocarbamol Oral Tablet 372831 SCDF
- Methocarbamol Oral Product 1162231 SCDG
- Methocarbamol Pill 1162232 SCDG
- Methocarbamol Oral Tablet [Tanlor] 2690999 SBDF
- Tanlor Oral Product 2690997 SBDG
- Tanlor Pill 2690998 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Methocarbamol 1000 MG 2611793 SCDC
- Methocarbamol 1000 MG Oral Tablet [Tanlor] 2691000 SBD
- Methocarbamol 1000 MG [Tanlor] 2690996 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Methocarbamol 1000 MG SCDC · 2611793
Methocarbamol Oral Tablet SCDF · 372831
Methocarbamol Oral Product SCDG · 1162231
Methocarbamol Pill SCDG · 1162232

Brand-Name Concepts

Methocarbamol 1000 MG Oral Tablet [Tanlor] SBD · 2691000
Methocarbamol 1000 MG [Tanlor] SBDC · 2690996
Methocarbamol Oral Tablet [Tanlor] SBDF · 2690999
Tanlor Oral Product SBDG · 2690997
Tanlor Pill SBDG · 2690998
Tanlor BN · 2690995

📦 FDA Products & Package NDCs

8 products · 11 package NDCs

11 package NDCs map to RxCUI 2611794 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00276-0510-10	100 TABLET, COATED in 1 BOTTLE, PLASTIC (0276-0510-10)	Methocarbamol	Misemer Pharmaceutical	2022-09-13
35561-0211-12	100 TABLET, COATED in 1 BOTTLE, PLASTIC (35561-211-12)	Methocarbamol	Bostal LLC	2018-10-09
35561-0211-13	500 TABLET, COATED in 1 BOTTLE, PLASTIC (35561-211-13)	Methocarbamol	Bostal LLC	2018-10-09
35561-0212-12	100 TABLET, COATED in 1 BOTTLE, PLASTIC (35561-212-12)	Methocarbamol	Bostal LLC	2018-10-10
35561-0212-13	500 TABLET, COATED in 1 BOTTLE, PLASTIC (35561-212-13)	Methocarbamol	Bostal LLC	2018-10-10
35561-0349-12	100 TABLET, COATED in 1 BOTTLE, PLASTIC (35561-349-12)	Methocarbamol	Bostal LLC	2022-07-16
35561-0349-13	500 TABLET, COATED in 1 BOTTLE, PLASTIC (35561-349-13)	Methocarbamol	Bostal LLC	2022-07-16
72245-0873-10	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72245-873-10)	Tanlor	Forte Bio-Pharma	2024-08-30
72887-0873-03	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72887-873-03)	methocarbamol	FH2 PHARMA LLC	2024-08-30
73352-0510-10	100 TABLET, COATED in 1 BOTTLE (73352-510-10)	Methocarbamol	Trifluent Pharma LLC	2025-02-10
85477-0101-10	100 TABLET, COATED in 1 BOTTLE, PLASTIC (85477-101-10)	Methocarbamol	Oncora Pharma, LLC	2025-11-20

Observed labelers: Bostal LLC (6) · FH2 PHARMA LLC (1) · Forte Bio-Pharma (1) · Misemer Pharmaceutical (1) · Oncora Pharma, LLC (1) · Trifluent Pharma LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.